Literature DB >> 19653720

Idiopathic fibroinflammatory disease of the face, eyelids, and periorbital membrane with immunoglobulin G4-positive plasma cells.

Manisha Mehta1, Frederick Jakobiec, Aaron Fay.   

Abstract

Progressive sclerosing orbital pseudotumors are a subset of usually primary and localized idiopathic fibroinflammatory disorders. We report on a 66-year-old man who developed this condition along the facial tissue planes with extension into the orbit and preferential involvement of the periorbital membrane. Fibrocollagenous tissue with scattered lymphoid aggregates without follicle formation dominated the process. There was a light dispersion of B and T lymphocytes and histiocytes in the stroma. Immunoglobulin G4 (IgG4)-positive plasma cells (>35 per high-power field) were identified mostly in the lymphoid clusters, as has been discovered in similar IgG4-related fibrosclerosing conditions of other nonorbital sites. No associated systemic disease emerged during a 20-year clinical course. Previously reported orbital cases of IgG4-positive disease have all involved the lacrimal gland, usually bilaterally, and more closely resembled hypercellular reactive lymphoid hyperplasias with moderate interlobular fibrosis, rather than representing an essentially sclerosing process from the beginning.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19653720     DOI: 10.5858/133.8.1251

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  20 in total

1.  IgG4 orbitopathy: unravelling a multisystem diagnostic challenge.

Authors:  N M Peter; R Khooshabeh; E J Soilleux
Journal:  Eye (Lond)       Date:  2012-04-27       Impact factor: 3.775

2.  Radiological features of IgG4-related disease in the head, neck, and brain.

Authors:  Masaki Katsura; Harushi Mori; Akira Kunimatsu; Hiroki Sasaki; Osamu Abe; Toru Machida; Kuni Ohtomo
Journal:  Neuroradiology       Date:  2012-02-23       Impact factor: 2.804

Review 3.  The Clinical and Pathological Features of IgG(4)-Related Disease.

Authors:  Arezou Khosroshahi; Vikram Deshpande; John H Stone
Journal:  Curr Rheumatol Rep       Date:  2011-12       Impact factor: 4.592

Review 4.  Autoimmune pancreatitis and IgG4-related systemic diseases.

Authors:  Lizhi Zhang; Thomas C Smyrk
Journal:  Int J Clin Exp Pathol       Date:  2010-05-25

Review 5.  Systemic immunoglobulin G4 (IgG4) disease and idiopathic orbital inflammation; removing 'idiopathic' from the nomenclature?

Authors:  D Lindfield; K Attfield; A McElvanney
Journal:  Eye (Lond)       Date:  2012-02-03       Impact factor: 3.775

6.  Fibrosis, gene expression and orbital inflammatory disease.

Authors:  James T Rosenbaum; Dongseok Choi; David J Wilson; Hans E Grossniklaus; Christina A Harrington; Roger A Dailey; John D Ng; Eric A Steele; Craig N Czyz; Jill A Foster; David Tse; Chris Alabiad; Sander Dubovy; Prashant Parekh; Gerald J Harris; Michael Kazim; Payal Patel; Valerie White; Peter Dolman; Deepak P Edward; Hind Alkatan; Hailah Al Hussain; Dinesh Selva; Patrick Yeatts; Bobby Korn; Don Kikkawa; Patrick Stauffer; Stephen R Planck
Journal:  Br J Ophthalmol       Date:  2015-06-02       Impact factor: 4.638

Review 7.  Clinicopathologic features of orbital immunoglobulin G4-related disease (IgG4-RD): a case series and literature review.

Authors:  Kaustubh Mulay; Ekta Aggarwal; Santosh G Honavar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-01-10       Impact factor: 3.117

8.  A new category for chronic sclerosing sialadenitis as an IgG4 related syndrome.

Authors:  Kazuki Nagai; Kazuo Andoh; Akira Ogata; Noriaki Aoki; Noriko Nakamura; Hiroo Hosaka; Rika Kurihara
Journal:  BMJ Case Rep       Date:  2010-03-26

Review 9.  Immunoglobulin G4-Related Disease: An Update.

Authors:  Abdullah Al-Mujaini; Murtadha Al-Khabori; Kashinatha Shenoy; Upender Wali
Journal:  Oman Med J       Date:  2018-03

10.  Location and frequency of lesions in patients with IgG4-related ophthalmic diseases.

Authors:  Yuka Sogabe; Koh-ichi Ohshima; Atsushi Azumi; Masayuki Takahira; Satoru Kase; Hideki Tsuji; Hiroshi Yoshikawa; Tetsuya Nakamura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-01-03       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.